Audio Player | The Diane Rehm Show from WAMU and NPR

On Now:

FDA Drug Approval Process

August 19, 2010

An FDA advisory board recommended withdrawing government approval for the breast cancer drug, Avastin. Pros and cons of the decision and its implications for FDA's accelerated approval process to treat serious and life threatening diseases.

Please install Adobe Flash Player.